Endovia Health Sciences, Inc. EDVA
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | -25.23M | -31.07M | -25.90M |
| Total Depreciation and Amortization | -- | -- | 318.20K | 513.80K | 611.90K |
| Total Amortization of Deferred Charges | -- | -- | 2.45M | 2.63M | 3.43M |
| Total Other Non-Cash Items | -- | -- | 14.68M | 18.26M | 10.70M |
| Change in Net Operating Assets | -- | -- | 3.00M | 4.22M | 5.49M |
| Cash from Operations | -- | -- | -4.79M | -5.45M | -5.67M |
| Capital Expenditure | -- | -- | -- | 0.00 | -3.20K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -1.50K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | 0.00 | -4.70K |
| Total Debt Issued | -- | -- | 4.38M | 5.21M | 5.78M |
| Total Debt Repaid | -- | -- | -580.20K | -722.10K | -802.00K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | 1.30M | 800.00K | 651.00K |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | 5.10M | 5.29M | 5.62M |
| Foreign Exchange rate Adjustments | -- | -- | -47.40K | -27.30K | 59.10K |
| Miscellaneous Cash Flow Adjustments | -- | -- | 0.00 | 0.00 | 0.00 |
| Net Change in Cash | -- | -- | 267.70K | -191.10K | 9.00K |